{
    "clinical_study": {
        "@rank": "191",
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on April 07, 2020",
            "link_text": "Link to the current ClinicalTrials.gov record.",
            "url": "https://clinicaltrials.gov/show/NCT04312100"
        },
        "id_info": {
            "org_study_id": "SOT-C",
            "nct_id": "NCT04312100"
        },
        "brief_title": "Sequential Oxygen Therapy Strategy for Patients With COVID-19",
        "acronym": "SOTSPC",
        "official_title": "Sequential Oxygen Therapy Strategy for Patients With COVID-19",
        "sponsors": {
            "lead_sponsor": {
                "agency": "Henan Provincial People's Hospital",
                "agency_class": "Other"
            }
        },
        "source": "Henan Provincial People's Hospital",
        "oversight_info": {
            "has_dmc": "No",
            "is_fda_regulated_drug": "No",
            "is_fda_regulated_device": "No",
            "is_us_export": "No"
        },
        "brief_summary": {
            "textblock": "All patients with COVID-19 were divided into three groups according to their illness: mild\n      patient who receive conventional oxygen therapy, severe patients who receive nasal high flow\n      oxygen inhalation or non-invasive positive pressure ventilation\uff0call the oxygen therapy will\n      be used as part of the standard of care. Each group will enroll 10 patients, the treatment of\n      all patients will be continuously optimized during observation, and the incidence of\n      respiratory failure, intubation rate, 28 day mortality rate, ICU hospitalization days, etc\n      will be recorded and analyzed so to optimize the treatment time window of sequential oxygen\n      therapy"
        },
        "overall_status": "Recruiting",
        "start_date": {
            "@type": "Actual",
            "#text": "February 1, 2020"
        },
        "completion_date": {
            "@type": "Anticipated",
            "#text": "February 2021"
        },
        "primary_completion_date": {
            "@type": "Anticipated",
            "#text": "October 2020"
        },
        "study_type": "Observational",
        "has_expanded_access": "No",
        "study_design_info": {
            "observational_model": "Cohort",
            "time_perspective": "Prospective"
        },
        "primary_outcome": {
            "measure": "Incidence of respiratory failure",
            "time_frame": "28 day",
            "description": "Incidence of respiratory failure at day 28 after enrollment"
        },
        "secondary_outcome": {
            "measure": "28 day mortality rate",
            "time_frame": "28 day",
            "description": "mortality rate at day 28 after enrollment"
        },
        "number_of_groups": "3",
        "enrollment": {
            "@type": "Anticipated",
            "#text": "30"
        },
        "condition": "Coronavirus Disease-2019",
        "arm_group": [
            {
                "arm_group_label": "Mild cases with conventional oxygen therapy",
                "description": "COVID-19 patients who were considered mild cases will receive conventional oxygen therapy in addition to standard treatment"
            },
            {
                "arm_group_label": "Moderate/Severe cases with nasal high flow oxygen inhalation",
                "description": "COVID-19 patients who were considered Moderate/Severe cases will receive nasal high flow oxygen inhalation in addition to standard treatment"
            },
            {
                "arm_group_label": "Moderate/Severe cases with non-invasive ventilation",
                "description": "COVID-19 patients who were considered Moderate/Severe cases will receive non-invasive positive pressure ventilation in addition to standard treatment"
            }
        ],
        "intervention": {
            "intervention_type": "Other",
            "intervention_name": "oxygen treatment",
            "description": "different kinds of oxygen treatments will be given to patients according to their state of illness",
            "arm_group_label": [
                "Mild cases with conventional oxygen therapy",
                "Moderate/Severe cases with nasal high flow oxygen inhalation",
                "Moderate/Severe cases with non-invasive ventilation"
            ]
        },
        "eligibility": {
            "study_pop": {
                "textblock": "Only patients diagnosed with COVID-19 will be enrolled, diagnosis will depend on RT-PRC\n        provided by China CDC"
            },
            "sampling_method": "Non-Probability Sample",
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients diagnosed with COVID-19\n\n               -  Aged between 18-75 years;\n\n                    -  Willing to sign the informed consent voluntarily.\n\n        Exclusion Criteria:\n\n          -  Patients with active tuberculosis, idiopathic pulmonary fibrosis, bronchial asthma,\n             bronchiectasis, pulmonary embolism, chronic respiratory failure or other serious\n             respiratory diseases; \u2461 patients with serious cardiovascular and cerebrovascular\n             diseases (malignant arrhythmia, unstable angina, acute myocardial infarction, cardiac\n             function grade 3 or above, stroke, cerebral hemorrhage, etc.); \u2462 Patients with serious\n             hepatorenal diseases (serious liver diseases refer to cirrhosis, portal hypertension\n             and varicose bleeding, and serious kidney diseases include dialysis and kidney\n             transplantation); \u2463 tumor patients who have undergone resection, radiotherapy and\n             chemotherapy within 5 years; \u2464 patients who have difficulty in activity due to\n             neuromuscular diseases; \u2465 patients with serious arthritis; \u2466 patients with serious\n             peripheral vascular diseases; \u2467 Pregnant and lactating women; \u2468 with severe cognitive\n             and mental disorders; \u2469 the clinical researchers who were participating in other\n             interventions within one month before selection;"
            },
            "gender": "All",
            "minimum_age": "18 Years",
            "maximum_age": "75 Years",
            "healthy_volunteers": "No"
        },
        "overall_official": {
            "last_name": "Xiaoju Zhang, PhD",
            "role": "Principal Investigator",
            "affiliation": "Henan Provincial People's Hospital"
        },
        "overall_contact": {
            "last_name": "Ziqi Wang, MD",
            "phone": "+86-13781919609",
            "email": "13781919609@163.com"
        },
        "location": {
            "facility": {
                "name": "Henan Provincial People's Hospital",
                "address": {
                    "city": "Zhengzhou",
                    "state": "Henan",
                    "zip": "450000",
                    "country": "China"
                }
            },
            "status": "Recruiting",
            "contact": {
                "last_name": "Li Li, Master",
                "phone": "+86-13619842879",
                "email": "sykyxmbgs@163.com"
            }
        },
        "location_countries": {
            "country": "China"
        },
        "link": {
            "url": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4369385/",
            "description": "Related Info"
        },
        "reference": [
            {
                "citation": "Chan JF, Lau SK, To KK, Cheng VC, Woo PC, Yuen KY. Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease. Clin Microbiol Rev. 2015 Apr;28(2):465-522. doi: 10.1128/CMR.00102-14. Review.",
                "PMID": "25810418"
            },
            {
                "citation": "Wu P, Hao X, Lau EHY, Wong JY, Leung KSM, Wu JT, Cowling BJ, Leung GM. Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020. Euro Surveill. 2020 Jan;25(3). doi: 10.2807/1560-7917.ES.2020.25.3.2000044.",
                "PMID": "31992388"
            }
        ],
        "verification_date": "March 2020",
        "study_first_submitted": "March 13, 2020",
        "study_first_submitted_qc": "March 14, 2020",
        "study_first_posted": {
            "@type": "Actual",
            "#text": "March 18, 2020"
        },
        "last_update_submitted": "March 14, 2020",
        "last_update_submitted_qc": "March 14, 2020",
        "last_update_posted": {
            "@type": "Actual",
            "#text": "March 18, 2020"
        },
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        },
        "keyword": [
            "SARS-CoV-2",
            "COVID-19",
            "oxygen treatment"
        ],
        "condition_browse": {
            "mesh_term": "Coronavirus Infections"
        },
        "patient_data": {
            "sharing_ipd": "No"
        }
    }
}